Skip to main content
logo
Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.3713
-0.0028 (-0.75%)
Sep 15, 2025, 10:27 AM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy
19.63M
Log In
Log In
Log In
Log In
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy Growth
31.59%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
19.63M
Log In
Log In
Log In
Log In
United States Growth
31.59%
Log In
Log In
Log In
Log In